TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,025,187 | +378.8% | 640,882 | 0.0% | 0.13% | +465.2% |
| Q2 2023 | $422,982 | -17.5% | 640,882 | 0.0% | 0.02% | -17.9% |
| Q1 2023 | $512,706 | -64.6% | 640,882 | 0.0% | 0.03% | -66.7% |
| Q4 2022 | $1,448,393 | +17.1% | 640,882 | 0.0% | 0.08% | +33.3% |
| Q3 2022 | $1,237,000 | -48.1% | 640,882 | 0.0% | 0.06% | -51.2% |
| Q2 2022 | $2,384,000 | -43.0% | 640,882 | 0.0% | 0.13% | -5.1% |
| Q1 2022 | $4,179,000 | -44.0% | 640,882 | 0.0% | 0.14% | -24.4% |
| Q4 2021 | $7,466,000 | -37.4% | 640,882 | 0.0% | 0.18% | -36.4% |
| Q3 2021 | $11,933,000 | -12.2% | 640,882 | 0.0% | 0.28% | +2.2% |
| Q2 2021 | $13,587,000 | +4.4% | 640,882 | 0.0% | 0.28% | -47.1% |
| Q1 2021 | $13,010,000 | -23.5% | 640,882 | 0.0% | 0.52% | -35.8% |
| Q4 2020 | $17,009,000 | +18.5% | 640,882 | 0.0% | 0.82% | +21.1% |
| Q3 2020 | $14,356,000 | – | 640,882 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |